Nightingale Health Oyj (FRA:7XE)
Germany
· Delayed Price · Currency is EUR 2.095
-0.015 (-0.71%)
Last updated: Dec 5, 2025, 8:03 AM CET
Nightingale Health Oyj Income Statement
Financials in millions EUR. Fiscal year is July - June.
Millions EUR. Fiscal year is Jul - Jun.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 | Jun '21 Jun 30, 2021 | 2020 - 2017 |
| Revenue | 4.69 | 4.36 | 4.18 | 2.31 | 2.31 | Upgrade
|
| Revenue Growth (YoY) | 7.69% | 4.21% | 80.80% | 0.35% | 29.43% | Upgrade
|
| Cost of Revenue | 1.16 | 1.46 | 0.59 | 1.04 | 0.32 | Upgrade
|
| Gross Profit | 3.54 | 2.9 | 3.59 | 1.28 | 1.99 | Upgrade
|
| Selling, General & Admin | 8.6 | 8.78 | 9.38 | 6.5 | 6.37 | Upgrade
|
| Other Operating Expenses | 6.03 | 4.51 | 6.01 | 4.14 | 3.05 | Upgrade
|
| Operating Expenses | 22.92 | 21.46 | 22.08 | 14.89 | 11.87 | Upgrade
|
| Operating Income | -19.38 | -18.56 | -18.49 | -13.61 | -9.88 | Upgrade
|
| Interest Expense | -0.01 | -0.01 | -0 | -0.77 | -0.37 | Upgrade
|
| Earnings From Equity Investments | -0.04 | -0.03 | -0.03 | -0.02 | 0.13 | Upgrade
|
| Currency Exchange Gain (Loss) | -0.15 | -0.27 | -0.37 | 0.3 | -0.06 | Upgrade
|
| Other Non Operating Income (Expenses) | 1.17 | 1.5 | 0.82 | -0.03 | 0.46 | Upgrade
|
| EBT Excluding Unusual Items | -18.41 | -17.38 | -18.07 | -14.13 | -9.72 | Upgrade
|
| Gain (Loss) on Sale of Investments | - | - | - | -2.07 | - | Upgrade
|
| Pretax Income | -18.41 | -17.38 | -18.07 | -16.19 | -9.72 | Upgrade
|
| Income Tax Expense | 0.05 | 0.09 | 0.01 | -0.1 | 0 | Upgrade
|
| Net Income | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 | Upgrade
|
| Net Income to Common | -18.46 | -17.46 | -18.08 | -16.09 | -9.73 | Upgrade
|
| Shares Outstanding (Basic) | 60 | 60 | 60 | 60 | 42 | Upgrade
|
| Shares Outstanding (Diluted) | 60 | 60 | 60 | 60 | 42 | Upgrade
|
| Shares Change (YoY) | 0.01% | - | 0.17% | 44.56% | 22.85% | Upgrade
|
| EPS (Basic) | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 | Upgrade
|
| EPS (Diluted) | -0.31 | -0.29 | -0.30 | -0.27 | -0.23 | Upgrade
|
| Free Cash Flow | -12.39 | -10.62 | -8.16 | -8.85 | -2.77 | Upgrade
|
| Free Cash Flow Per Share | -0.20 | -0.18 | -0.14 | -0.15 | -0.07 | Upgrade
|
| Gross Margin | 75.39% | 66.45% | 85.89% | 55.17% | 86.16% | Upgrade
|
| Operating Margin | -412.95% | -425.86% | -442.16% | -588.46% | -428.59% | Upgrade
|
| Profit Margin | -393.37% | -400.71% | -432.40% | -695.68% | -421.91% | Upgrade
|
| Free Cash Flow Margin | -263.90% | -243.62% | -195.17% | -382.49% | -120.04% | Upgrade
|
| EBITDA | -14.5 | -14.06 | -14.96 | -11.53 | -9.3 | Upgrade
|
| D&A For EBITDA | 4.88 | 4.5 | 3.53 | 2.08 | 0.58 | Upgrade
|
| EBIT | -19.38 | -18.56 | -18.49 | -13.61 | -9.88 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.